Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2011 1
2012 1
2014 2
2015 5
2016 5
2017 2
2018 5
2019 5
2020 8
2021 3
2022 8
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Bisphosphonate therapy for osteogenesis imperfecta.
Dwan K, Phillipi CA, Steiner RD, Basel D. Dwan K, et al. Cochrane Database Syst Rev. 2016 Oct 19;10(10):CD005088. doi: 10.1002/14651858.CD005088.pub4. Cochrane Database Syst Rev. 2016. PMID: 27760454 Free PMC article. Review.
BACKGROUND: Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal type I collagen bone matrix which typically results in multiple fractures with little or no trauma. Bisphosphonates are used in an attempt to increase bone mineral density and …
BACKGROUND: Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal type I collagen bone matrix which t …
Should we offer prenatal exome sequencing for intrauterine growth restriction or short long bones? A systematic review and meta-analysis.
Mone F, Mellis R, Gabriel H, Baptiste C, Giordano J, Wapner R, Chitty LS. Mone F, et al. Am J Obstet Gynecol. 2023 Apr;228(4):409-417.e4. doi: 10.1016/j.ajog.2022.09.045. Epub 2022 Oct 7. Am J Obstet Gynecol. 2023. PMID: 36209938 Free article. Review.
Of the 37 short long bone cases with a diagnosis, 32 had a skeletal dysplasia, with thanatophoric dysplasia and osteogenesis imperfecta being the most common (both 21.6% [n=8/37]). In fetuses with short long bones and additional skeletal features, osteogenesis …
Of the 37 short long bone cases with a diagnosis, 32 had a skeletal dysplasia, with thanatophoric dysplasia and osteogenesis imper …
Malocclusion in individuals with osteogenesis imperfecta: A systematic review and meta-analysis.
Prado HV, Teixeira SA, Rabello F, Vargas-Ferreira F, Borges-Oliveira AC, Abreu LG. Prado HV, et al. Oral Dis. 2022 Mar;28(2):314-325. doi: 10.1111/odi.13715. Epub 2020 Nov 22. Oral Dis. 2022. PMID: 33222339 Review.
OBJECTIVE: To evaluate whether individuals with osteogenesis imperfecta (OI) are more affected by malocclusion than individuals without OI. ...
OBJECTIVE: To evaluate whether individuals with osteogenesis imperfecta (OI) are more affected by malocclusion than individual …
Dental Implants in People with Osteogenesis Imperfecta: A Systematic Review.
Oelerich O, Kleinheinz J, Bohner L, Wiesmüller V, Hanisch M. Oelerich O, et al. Int J Environ Res Public Health. 2022 Jan 29;19(3):1563. doi: 10.3390/ijerph19031563. Int J Environ Res Public Health. 2022. PMID: 35162583 Free PMC article. Review.
The aim of this systematic review was to answer the question of whether patients with osteogenesis imperfecta can be prosthetically rehabilitated with dental implants. A protocol was prospectively registered in PROSPERO (CRD42021286368). The inclusion criteria were …
The aim of this systematic review was to answer the question of whether patients with osteogenesis imperfecta can be prostheti …
Quality of life in osteogenesis imperfecta: A mixed-methods systematic review.
Dahan-Oliel N, Oliel S, Tsimicalis A, Montpetit K, Rauch F, Dogba MJ. Dahan-Oliel N, et al. Am J Med Genet A. 2016 Jan;170A(1):62-76. doi: 10.1002/ajmg.a.37377. Epub 2015 Sep 14. Am J Med Genet A. 2016. PMID: 26365089 Review.
Clinical interventions and research have mostly focused on the orthopedic, genetic, and pharmacological outcomes of individuals with osteogenesis imperfecta (OI), and although quality of life (QoL) has gained recognition as an important patient-outcome, it has recei …
Clinical interventions and research have mostly focused on the orthopedic, genetic, and pharmacological outcomes of individuals with oste …
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review.
Rapoport M, Bober MB, Raggio C, Wekre LL, Rauch F, Westerheim I, Hart T, van Welzenis T, Mistry A, Clancy J, Booth L, Prince S, Semler O. Rapoport M, et al. Orphanet J Rare Dis. 2023 Feb 22;18(1):34. doi: 10.1186/s13023-023-02627-3. Orphanet J Rare Dis. 2023. PMID: 36814274 Free PMC article. Review.
BACKGROUND: Osteogenesis imperfecta (OI) is a rare heritable connective tissue disorder primarily characterised by skeletal deformity and fragility, and an array of secondary features. ...
BACKGROUND: Osteogenesis imperfecta (OI) is a rare heritable connective tissue disorder primarily characterised by skeletal de …
Ocular characteristics and complications in patients with osteogenesis imperfecta: a systematic review.
Treurniet S, Burger P, Ghyczy EAE, Verbraak FD, Curro-Tafili KR, Micha D, Bravenboer N, Ralston SH, de Vries R, Moll AC, Eekhoff EMW. Treurniet S, et al. Acta Ophthalmol. 2022 Feb;100(1):e16-e28. doi: 10.1111/aos.14882. Epub 2021 May 19. Acta Ophthalmol. 2022. PMID: 34009739 Free PMC article.
PURPOSE: Osteogenesis imperfecta (OI) is a rare inherited heterogeneous connective tissue disorder characterized by bone fragility, low bone mineral density, skeletal deformity and blue sclera. ...
PURPOSE: Osteogenesis imperfecta (OI) is a rare inherited heterogeneous connective tissue disorder characterized by bone fragi …
Heart disease in patients with osteogenesis imperfecta - A systematic review.
Ashournia H, Johansen FT, Folkestad L, Diederichsen AC, Brixen K. Ashournia H, et al. Int J Cardiol. 2015 Oct 1;196:149-57. doi: 10.1016/j.ijcard.2015.06.001. Epub 2015 Jun 14. Int J Cardiol. 2015. PMID: 26100571 Review.
INTRODUCTION: Osteogenesis imperfecta (OI) is a rare, inherited systemic connective tissue disease that causes decreased bioavailability of collagen type 1. ...
INTRODUCTION: Osteogenesis imperfecta (OI) is a rare, inherited systemic connective tissue disease that causes decreased bioav …
Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy.
Ugarteburu M, Cardoso L, Richter CP, Carriero A. Ugarteburu M, et al. Sci Rep. 2022 Oct 12;12(1):17125. doi: 10.1038/s41598-022-20169-9. Sci Rep. 2022. PMID: 36224204 Free PMC article.
About 70% of people with osteogenesis imperfecta (OI) experience hearing loss. There is no cure for OI, and therapies to ameliorate hearing loss rely on conventional treatments for auditory impairments in the general population. ...
About 70% of people with osteogenesis imperfecta (OI) experience hearing loss. There is no cure for OI, and therapies to ameli …
Severe osteogenesis imperfecta Type-III and its challenging treatment in newborn and preschool children. A systematic review.
Sinikumpu JJ, Ojaniemi M, Lehenkari P, Serlo W. Sinikumpu JJ, et al. Injury. 2015 Aug;46(8):1440-6. doi: 10.1016/j.injury.2015.04.021. Epub 2015 Apr 22. Injury. 2015. PMID: 25943292 Review.
Osteogenesis imperfecta (OI) is a group of genetic disorders, of which Type III is the most severe among survivors. ...
Osteogenesis imperfecta (OI) is a group of genetic disorders, of which Type III is the most severe among survivors. ...
46 results